. "By actively scaling our Life Sciences & Healthcare division, wewill solidify our position as the leading provider of end-to-endsolutions across the entire value chain. This not only increasesvalue for our customers by supporting them in meeting changingpatient needs, but ultimately improves patient outcomes."
Ruth Beadle, Head of Global Supply Chain for Sanofi states: "We aredelighted to partner with DHL to continue delivering the highestquality products in a sustainable way from France. We stronglybelieve that the Amilly, Croissy Beaubourg and Saint-Loubèsdistribution centers with its employees will continue to exercisesame strive for excellence with DHL, through a new journey thatwill bring the most value to our customers and patients in Franceand all around the world".
Leveraging its expert resources, investments, and internationalnetwork in the life sciences and healthcare sector, DHL SupplyChain aims to enhance the efficiency, resiliency and high-qualitystandards of Sanofi's logistics network. This partnership isfurther reinforced by DHL's experience across various segments,including pharmaceuticals, biopharmaceuticals, consumer health,vaccines, medical devices, clinical trials, hospitals, andhealthcare establishments.
"Our dedicated team is highly trained and experienced in handlingthe specific requirements of life science products. We have theinfrastructure, technology and know-how to ensure quality assuranceand rigorous compliance with French regulation" added Nico Schütz,CEO DHL Supply Chain France. "This strategic agreement serves as alever to further develop our Life Sciences and Healthcare divisionin France and the wider region."
Beyond the immediate impact on the French market, the partnershipwith Sanofi holds strategic importance for DHL, aligning with itsvision for growth in the region and leveraging its globalfootprint in the life sciences and healthcare sector.
